Transgender hormone therapy (male-to-female) medical professional. Inducers of CYP3A4 and other cytochrome P450 enzymes can reduce the effects of MTF HRT. A variety of different sex-hormonal medications are used in feminizing hormone therapy for transgender women. These include estrogens to induce feminization and suppress testosterone levels; antiandrogens such as androgen receptor antagonists, antigonadotropins, GnRH modulators, and 5α-reductase inhibitors to further oppose the effects of androgens like testosterone; and progestogens for various possible though uncertain benefits. Estrogens are the major sex hormones in women, and are responsible for the development and maintenance of feminine secondary sexual characteristics, such as breasts, wide hips, and a feminine
Fraternal birth order and male sexual orientation not non-biological older brothers predicted sexual orientation in men. Further, if rearing or social factors underlie the fraternal birth order effect, then the amount of time reared with older brothers, either biological or non-biological, should predict sexual orientation because rearing time determines the relative opportunity that older brothers have to affect their younger sibling's (postnatal) sociosexual development. If a prenatal factor underlies the fraternal birth order effect, then a postnatal factor such as rearing time with older siblings (be they biological or non-biological) should have no impact on the sexual orientation of younger male siblings. The study found that the